Firefly Neuroscience Gross Profit Growth & History (AIFF)
Firefly Neuroscience's gross profit was $645,000 for fiscal 2025.
View full Firefly Neuroscience company overviewFirefly Neuroscience annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $645,000 | $537,000 | +497.22% |
| 2024 | 2024-12-31 | $108,000 | −$2.5M | −95.87% |
| 2023 | 2023-12-31 | $2.6M | −$248,547 | −8.68% |
| 2022 | 2022-12-31 | $2.9M | −$752,772 | −20.82% |
| 2021 | 2021-12-31 | $3.6M | $1.4M | +63.65% |
| 2020 | 2020-12-31 | $2.2M | $809,354 | +57.81% |
| 2019 | 2019-12-31 | $1.4M | −$742,859 | −34.67% |
| 2018 | 2018-12-31 | $2.1M | −$272,591 | −11.29% |
| 2017 | 2017-12-31 | $2.4M | $592,767 | +32.52% |
| 2016 | 2016-12-31 | $1.8M | −$549,891 | −23.18% |
| 2015 | 2015-12-31 | $2.4M | −$14,992 | −0.63% |
| 2014 | 2014-12-31 | $2.4M | $128,091 | +5.67% |
| 2013 | 2013-12-31 | $2.3M | −$151,528 | −6.28% |
| 2012 | 2012-12-31 | $2.4M | −$31,272 | −1.28% |
| 2011 | 2011-12-31 | $2.4M | $56,465 | +2.37% |
| 2010 | 2010-12-31 | $2.4M | — | — |
Firefly Neuroscience quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $253,000 | −$21,000 | −7.66% |
| Q1 2026 | 2026-03-31 | $221,000 | $178,000 | +413.95% |
| Q4 2025 | 2025-12-31 | $182,000 | $816,258 | — |
| Q3 2025 | 2025-09-30 | $146,000 | $113,000 | +342.42% |
| Q2 2025 | 2025-06-30 | $274,000 | $264,000 | +2640.00% |
| Q1 2025 | 2025-03-31 | $43,000 | −$656,258 | −93.85% |
| Q4 2024 | 2024-12-31 | −$634,258 | −$1.2M | — |
| Q3 2024 | 2024-09-30 | $33,000 | −$616,812 | −94.92% |
| Q2 2024 | 2024-06-30 | $10,000 | −$695,013 | −98.58% |
| Q1 2024 | 2024-03-31 | $699,258 | $42,460 | +6.46% |
| Q4 2023 | 2023-12-31 | $602,674 | $78,737 | +15.03% |
| Q3 2023 | 2023-09-30 | $649,812 | −$88,784 | −12.02% |
| Q2 2023 | 2023-06-30 | $705,013 | −$198,828 | −22.00% |
| Q1 2023 | 2023-03-31 | $656,798 | −$39,672 | −5.70% |
| Q4 2022 | 2022-12-31 | $523,937 | −$137,226 | −20.76% |
| Q3 2022 | 2022-09-30 | $738,596 | −$240,279 | −24.55% |
| Q2 2022 | 2022-06-30 | $903,841 | −$52,087 | −5.45% |
| Q1 2022 | 2022-03-31 | $696,470 | −$323,180 | −31.70% |
| Q4 2021 | 2021-12-31 | $661,163 | −$266,000 | −28.69% |
| Q3 2021 | 2021-09-30 | $978,875 | $364,548 | +59.34% |
| Q2 2021 | 2021-06-30 | $955,928 | $566,912 | +145.73% |
| Q1 2021 | 2021-03-31 | $1.0M | $740,823 | +265.69% |
| Q4 2020 | 2020-12-31 | $927,163 | $591,101 | +175.89% |
| Q3 2020 | 2020-09-30 | $614,327 | $230,010 | +59.85% |
| Q2 2020 | 2020-06-30 | $389,016 | $32,255 | +9.04% |
| Q1 2020 | 2020-03-31 | $278,827 | −$44,012 | −13.63% |
| Q4 2019 | 2019-12-31 | $336,062 | −$131,895 | −28.19% |
| Q3 2019 | 2019-09-30 | $384,317 | −$184,789 | −32.47% |
| Q2 2019 | 2019-06-30 | $356,761 | −$198,593 | −35.76% |
| Q1 2019 | 2019-03-31 | $322,839 | −$227,582 | −41.35% |
| Q4 2018 | 2018-12-31 | $467,957 | −$174,396 | −27.15% |
| Q3 2018 | 2018-09-30 | $569,106 | −$66,785 | −10.50% |
| Q2 2018 | 2018-06-30 | $555,354 | −$81,986 | −12.86% |
| Q1 2018 | 2018-03-31 | $550,421 | $50,576 | +10.12% |
| Q4 2017 | 2017-12-31 | $642,353 | $259,195 | +67.65% |
| Q3 2017 | 2017-09-30 | $635,891 | $79,806 | +14.35% |
| Q2 2017 | 2017-06-30 | $637,340 | $111,594 | +21.23% |
| Q1 2017 | 2017-03-31 | $499,845 | $142,172 | +39.75% |
| Q4 2016 | 2016-12-31 | $383,158 | −$624,680 | −61.98% |
| Q3 2016 | 2016-09-30 | $556,085 | $111,828 | +25.17% |
| Q2 2016 | 2016-06-30 | $525,746 | $89,543 | +20.53% |
| Q1 2016 | 2016-03-31 | $357,673 | −$126,582 | −26.14% |
| Q4 2015 | 2015-12-31 | $1.0M | −$4,108 | −0.41% |
| Q3 2015 | 2015-09-30 | $444,257 | −$159,895 | −26.47% |
| Q2 2015 | 2015-06-30 | $436,203 | $119,034 | +37.53% |
| Q1 2015 | 2015-03-31 | $484,255 | $29,977 | +6.60% |
| Q4 2014 | 2014-12-31 | $1.0M | $424,459 | +72.25% |
| Q3 2014 | 2014-09-30 | $604,152 | −$151,365 | −20.03% |
| Q2 2014 | 2014-06-30 | $317,169 | −$86,217 | −21.37% |
| Q1 2014 | 2014-03-31 | $454,278 | −$58,786 | −11.46% |
| Q4 2013 | 2013-12-31 | $587,487 | −$4,240 | −0.72% |
| Q3 2013 | 2013-09-30 | $755,517 | $185,679 | +32.58% |
| Q2 2013 | 2013-06-30 | $403,386 | −$313,344 | −43.72% |
| Q1 2013 | 2013-03-31 | $513,064 | −$19,623 | −3.68% |
| Q4 2012 | 2012-12-31 | $591,727 | −$51,020 | −7.94% |
| Q3 2012 | 2012-09-30 | $569,838 | −$112,606 | −16.50% |
| Q2 2012 | 2012-06-30 | $716,730 | $154,105 | +27.39% |
| Q1 2012 | 2012-03-31 | $532,687 | −$21,751 | −3.92% |
| Q4 2011 | 2011-12-31 | $642,747 | — | — |
| Q3 2011 | 2011-09-30 | $682,444 | $46,535 | +7.32% |
| Q2 2011 | 2011-06-30 | $562,625 | $54 | +0.01% |
| Q1 2011 | 2011-03-31 | $554,438 | — | — |
| Q3 2010 | 2010-09-30 | $635,909 | — | — |
| Q2 2010 | 2010-06-30 | $562,571 | — | — |
Firefly Neuroscience gross profit trends
Over the last five fiscal years, Firefly Neuroscience's gross profit decreased from $2.2M to $645,000, a change of −$1.6M. The latest reported quarter, Q2 2026, shows $253,000.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Firefly Neuroscience source filings ↗